Siddappa N. Byrareddy

Siddappa N. Byrareddy

University of Nebraska Medical Center

H-index: 41

North America-United States

About Siddappa N. Byrareddy

Siddappa N. Byrareddy, With an exceptional h-index of 41 and a recent h-index of 33 (since 2020), a distinguished researcher at University of Nebraska Medical Center, specializes in the field of HIV/SIV, Substance Abuse, Inflammation, COVID-19, ZIka.

His recent articles reflect a diverse array of research interests and contributions to the field:

Emergence of SARS-CoV-2 Omicron Variant JN. 1 in Tamil Nadu, India ̶ Clinical Characteristics and Novel Mutations

ChatGPT’s scorecard after the performance in a series of tests conducted at the multi-university level: A pattern of responses of generative artificial intelligence or large …

TISSUE-SPECIFIC METABOLOMIC REPROGRAMMING DETERMINES THE DISEASE PATHOPHYSIOLOGY OF SARS-COV-2 VARIANTS IN HAMSTER MODEL

SARS-CoV-2 Omicron Spike shows strong binding affinity and favourable interaction landscape with the TLR4/MD2 compared to other variants

Host peripheral immune dynamics increase HIV-associated neurocognitive disorders incidence and progression

Comparative analysis of human gut-and blood-derived mononuclear cells: contrasts in function and phenotype

Genomic surveillance of omicron B. 1.1. 529 SARS‐CoV‐2 and its variants between December 2021 and March 2023 in Tamil Nadu, India—A state‐wide prospective longitudinal study

Islatravir: evaluation of clinical development for HIV and HBV

Siddappa N. Byrareddy Information

University

Position

___

Citations(all)

15112

Citations(since 2020)

12269

Cited By

7377

hIndex(all)

41

hIndex(since 2020)

33

i10Index(all)

113

i10Index(since 2020)

94

Email

University Profile Page

University of Nebraska Medical Center

Google Scholar

View Google Scholar Profile

Siddappa N. Byrareddy Skills & Research Interests

HIV/SIV

Substance Abuse

Inflammation

COVID-19

ZIka

Top articles of Siddappa N. Byrareddy

Title

Journal

Author(s)

Publication Date

Emergence of SARS-CoV-2 Omicron Variant JN. 1 in Tamil Nadu, India ̶ Clinical Characteristics and Novel Mutations

medRxiv

Sivaprakasam T Selvavinayagam

Sathish Sankar

Yean K Yong

Amudhan Murugesan

Suvaiyarasan Suvaithenamudhan

...

2024

ChatGPT’s scorecard after the performance in a series of tests conducted at the multi-university level: A pattern of responses of generative artificial intelligence or large …

Current Research in Biotechnology

Manojit Bhattacharya

Soumen Pal

Srijan Chatterjee

Abdulrahman Alshammari

Thamer H Albekairi

...

2024/3/2

TISSUE-SPECIFIC METABOLOMIC REPROGRAMMING DETERMINES THE DISEASE PATHOPHYSIOLOGY OF SARS-COV-2 VARIANTS IN HAMSTER MODEL

bioRxiv

Urvinder Kaur Sardarni

Anoop Ambikan

Arpan Acharya

Samuel D Johnson

Sean N Avedissian

...

2024

SARS-CoV-2 Omicron Spike shows strong binding affinity and favourable interaction landscape with the TLR4/MD2 compared to other variants

Journal of Genetic Engineering and Biotechnology

Chiranjib Chakraborty

Bidyut Mallick

Manojit Bhattacharya

Siddappa N Byrareddy

2024/3/1

Host peripheral immune dynamics increase HIV-associated neurocognitive disorders incidence and progression

Samuel D Johnson

Reema S Guda

Narendra Kumar

Siddappa N Byrareddy

2024/1/1

Comparative analysis of human gut-and blood-derived mononuclear cells: contrasts in function and phenotype

Frontiers in immunology

Stephanie C Burke Schinkel

Priscila O Barros

Tamara Berthoud

Siddappa N Byrareddy

Michaeline McGuinty

...

2024/2/20

Genomic surveillance of omicron B. 1.1. 529 SARS‐CoV‐2 and its variants between December 2021 and March 2023 in Tamil Nadu, India—A state‐wide prospective longitudinal study

Journal of Medical Virology

Sivaprakasam T Selvavinayagam

Suvaiyarasan Suvaithenamudhan

Yean K Yong

Kannan Hemashree

Manivannan Rajeshkumar

...

2024/2

Islatravir: evaluation of clinical development for HIV and HBV

Samuel W Gillespie

Athreya S Reddy

Dana M Burris

S Hasan Naqvi

Siddappa N Byrareddy

...

2024/2/1

Dual role for microbial short-chain fatty acids in modifying SIV disease trajectory following anti-α4β7 antibody administration

Annals of Medicine

Samuel D Johnson

Nageswara Pilli

Jianshi Yu

Lindsey A Knight

Maureen A Kane

...

2024/12/31

Plasma CXCL8 and MCP-1 as biomarkers of latent tuberculosis infection

medRxiv

Sivaprakasam T Selvavinayagam

Bijulal Aswathy

Yean K Yong

Asha Frederick

Lakshmi Murali

...

2023/8/9

Missing subunits of Mpox replication complex: Possible impact on structural organization

Journal of Infection

Saathvik R Kannan

Athreya S Reddy

Dana M Burris

Siddappa N Byrareddy

Kamal Singh

2023/11/1

Cannabinoid enhancement of lncRNA MMP25-AS1/MMP25 interaction reduces neutrophil infiltration and intestinal epithelial injury in HIV/SIV infection

JCI insight

Lakmini S Premadasa

Eunhee Lee

Marina McDew-White

Xavier Alvarez

Sahana Jayakumar

...

2023/4/4

Proteomic landscape of astrocytes and pericytes infected with HIV/SARS-CoV-2 mono/co-infection, impacting on neurological complications

Research Square

Arpan Acharya

Anoop T Ambikan

Michellie Thurman

Mohid Reza Malik

Shetty Ravi Dyavar

...

2023/6/12

Preclinical assessment of nirmatrelvir penetration into cerebrospinal fluid and central nervous system cells and tissues

Sean Avedissian

Johid Malik

Anthony Podany

Michael Neely

Nathaniel Rhodes

...

2023/10/12

Inflammation-Associated Lung Tissue Remodeling and Fibrosis in Morphine-Dependent SIV-Infected Macaques

The American Journal of Pathology

Divya T Chemparathy

Susmita Sil

Shannon Callen

Hitendra S Chand

Mohan Sopori

...

2023/4/1

Potential therapeutic targets for Mpox: the evidence to date

Siddappa N Byrareddy

Kalicharan Sharma

Shrikesh Sachdev

Athreya S Reddy

Arpan Acharya

...

2023/6/3

Efficient trapping and destruction of SARS-CoV-2 using PECO-assisted Molekule air purifiers in the laboratory and real-world settings

Ecotoxicology and Environmental Safety

Arpan Acharya

Kerri Surbaugh

Michellie Thurman

Chatura Wickramaratne

Philip Myers

...

2023/10/1

Engineering an ACE2-Derived Fragment as a Decoy for Novel SARS-CoV-2 Virus

ACS Pharmacology & Translational Science

Fabiana Renzi

Austin Seamann

Koelina Ganguly

Kabita Pandey

Siddappa N Byrareddy

...

2023/5/22

Clinical characteristics and novel mutations of omicron subvariant XBB in Tamil Nadu, India–a cohort study

The Lancet Regional Health - Southeast Asia

Sivaprakasam T Selvavinayagam

Sree Jith Karishma

Kannan Hemashree

Yean K Yong

Suvaiyarasan Suvaithenamudhan

...

2023/12

Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications

Zach J Leinen

Rahul Mohan

Lakmini S Premadasa

Arpan Acharya

Mahesh Mohan

...

2023/9/25

See List of Professors in Siddappa N. Byrareddy University(University of Nebraska Medical Center)

Co-Authors

H-index: 163
Antonio Lanzavecchia

Antonio Lanzavecchia

Università della Svizzera Italiana

H-index: 67
Sarah J. Ratcliffe

Sarah J. Ratcliffe

University of Virginia

H-index: 20
Hari Kishore Annavarapu

Hari Kishore Annavarapu

University of Texas Southwestern Medical Center

H-index: 15
Muhammad M Mukhtar

Muhammad M Mukhtar

Harvard University

academic-engine